Work

Abstract PS2-10-15: Prospective evaluation of a mRNA ERBB2 score as a tool to guide HER2 status and accelerate neoadjuvant decision-making in ER-negative breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-10-15

Authors: M. Gonzalez-Rodriguez, E. Sanfeliu, M. Alva, T. Pascual, S. Pernas, A. Waks, M. Vidal, P. Tarantino, E. Ciruelos, S. Tolaney, M. Marín-Aguilera, L. Paré, W. Buckingham, F. Brasó-Maristany, A. Prat

Institutions: Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario 12 De Octubre, Institut Català d'Oncologia, Harvard University, Dana-Farber/Harvard Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130688913

Cites:

Cited by:

Related to: